Ultrarare disease specialists top 2021's pricey drugs list, but Takeda, Merck KGaA meds rank, too

Mar 9, 2021 12:12pm
Eiger BioPharmaceuticals' Zokinvy, recently approved by the FDA for ultrarare rapid-aging diseases that affect an estimated 600 children worldwide, is the most expensive drug in U.S. pharmacies in 2021, according to GoodRx.(Jacoblund)
Eiger BioPharmaceuticals in November snagged FDA clearance for Zokinvy for ultra-rare rapid-aging diseases that affect an estimated 600 people worldwide. Orphan drugs that treat small patient populations typically come with high prices, but Zokinvy’s sticker price now beats them all in U.S. pharmacies.
At an estimated monthly price of $86,000, or more than $1 million a year, Zokinvy’s now the most expensive pharmacy drug in the U.S. as of February, according to a list compiled by GoodRx. The ranking focuses on monthly prices and doesn’t include drugs administered by doctors.

Related Keywords

,Eiger Onecare ,Zokinvy Orladeyo ,Amryt Pharma ,Pharma Europe ,Merck Kga ,Merck Kgaa ,Merck Co ,Bristol Myers Squibb ,Eiger Biopharmaceuticals ,Pharma Marketing ,Digital Pharma ,Biocryst Pharmaceutical ,Pharmaceutical Qinlock ,Myers Squibb ,Viekira Pak ,Agios Pharmaceuticals ,Biocryst Pharmaceuticals ,Deciphera ,Takeda ,Mavenclad ,Qinlock ,Idhifa Enasidenib ,Takhzyro ,Rare Diseases ,Drug Prices ,Orphan Drug ,Drug Costs ,Marketing ,பார்மா யூரோப் ,மெர்க் க்க ,மெர்க் இணை ,பிரிஸ்டல் மைஸ் ஸ்க்விப்ப் ,ஈகர் உயிர் மருந்துகள் ,பார்மா சந்தைப்படுத்தல் ,டிஜிட்டல் பார்மா ,மைஸ் ஸ்க்விப்ப் ,டாகேடா ,ரேர் நோய்கள் ,மருந்து ப்ரைஸஸ் ,ஆர்ஃபந் மருந்து ,மருந்து செலவுகள் ,சந்தைப்படுத்தல் ,